blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3990183

EP3990183 - BIOMOLECULE DIAGNOSTIC SYSTEMS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.04.2022
Database last updated on 21.05.2024
FormerThe international publication has been made
Status updated on  15.01.2021
Formerunknown
Status updated on  24.07.2020
Most recent event   Tooltip18.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Axbio Inc.
3350 Scott Blvd. Bldg. 9
Santa Clara, CA 95054 / US
[2022/18]
Inventor(s)01 / CHUEH, Albert
3350 Scott Blvd., Building 9
Santa Clara, CA 95054 / US
02 / DREYER, Stephen F.
3350 Scott Blvd., Building 9
Santa Clara, CA 95054 / US
03 / AGRAWAL, Priyanka
3350 Scott Blvd., Building 9
Santa Clara, CA 95054 / US
04 / IVANOV, Igor
3350 Scott Blvd., Building 9
Santa Clara, CA 95054 / US
05 / TIAN, Hui
3350 Scott Blvd., Building 9
Santa Clara, CA 95054 / US
 [2022/18]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[N/P]
Former [2022/18]Nieuwenhuys, William Francis
Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
Application number, filing date20740463.325.06.2020
[2022/18]
WO2020US39499
Priority number, dateUS201962867681P27.06.2019         Original published format: US 201962867681 P
[2022/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020264080
Date:30.12.2020
Language:EN
[2020/53]
Type: A1 Application with search report 
No.:EP3990183
Date:04.05.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2020 takes the place of the publication of the European patent application.
[2022/18]
Search report(s)International search report - published on:EP30.12.2020
ClassificationIPC:B01L3/00, B01L9/00
[2022/18]
CPC:
B01L3/502715 (EP); B01L3/502738 (US); B01L9/527 (EP);
B01L2200/025 (EP,US); B01L2200/026 (US); B01L2200/027 (EP);
B01L2200/147 (EP); B01L2300/0645 (EP,US); B01L2300/0816 (EP);
B01L2300/0867 (EP); B01L2400/0487 (EP); B01L2400/049 (EP);
B01L2400/0633 (EP,US); B01L2400/0638 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/18]
TitleGerman:BIOMOLEKÜLDIAGNOSESYSTEME[2022/18]
English:BIOMOLECULE DIAGNOSTIC SYSTEMS[2022/18]
French:SYSTÈMES DE DIAGNOSTIC DE BIOMOLÉCULES[2022/18]
Entry into regional phase22.12.2021National basic fee paid 
22.12.2021Designation fee(s) paid 
22.12.2021Examination fee paid 
Examination procedure22.12.2021Examination requested  [2022/18]
22.12.2021Date on which the examining division has become responsible
15.08.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
01.04.2022Renewal fee patent year 03
31.03.2023Renewal fee patent year 04
17.05.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5955028  (CHOW CALVIN Y H [US]) [X] 1,2,7,8 * columns 6-12; figure 2 *;
 [A]US2005003554  (BRASSEUR MICHAEL [US]) [A] 1-8* the whole document *;
 [X]US2005243304  (PADMANABHAN ARAVIND [US], et al) [X] 1-8 * paragraphs [0006] , [0051]; figures 1-4 *;
 [X]WO2017091618  (SPECTRADYNE LLC [US]) [X] 1-8 * pages 6-7; figures 1-4; example 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.